Originality benefit and difficulty of clinical research in the West Japan Lung Cancer Group : Originality, benefits and difficulties of clinical research performed by cooperative groupsKAWAHARA, Masaaki; ARIYOSHI, Yutaka; FUKUOKA, Masahiro et al.Critical reviews in oncology/hematology. 2000, Vol 36, Num 1, pp 9-12, issn 1040-8428Article

Skeletal metastases in non-small cell lung cancer : A retrospective studyTSUYA, Asuka; KURATA, Takayasu; TAMURA, Kenji et al.Lung cancer. 2007, Vol 57, Num 2, pp 229-232, issn 0169-5002, 4 p.Article

Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancerYAMAMOTO, Nobuyuki; NISHIMURA, Yasumasa; NAKAGAWA, Kazuhiko et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 3, pp 285-291, issn 0344-5704, 7 p.Article

Effects of suplatast tosilate (IPD Capsules®) on the production of active oxygen by neutrophils and of IL-8 by mononuclear cellsTOHDA, Yuji; KUBO, Hirokazu; HARAGUCHI, Ryuta et al.International immunopharmacology. 2001, Vol 1, Num 6, pp 1183-1187, issn 1567-5769Article

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, given weekly to advanced solid tumor patients for 3 weeksYAMAMOTO, Nobuyuki; ANDOH, Masahiro; KAWAHARA, Masaaki et al.Cancer science. 2009, Vol 100, Num 2, pp 316-321, issn 1347-9032, 6 p.Article

Clinical application of immunoreactivity of dihydropyrimidine dehydrogenase (DPD) in gastric scirrhous carcinoma treated with S-1, a new DPD inhibitory fluoropyrimidineSHIMIZU, Toshio; YAMADA, Yasuhide; YASUI, Hisateru et al.Anticancer research. 2005, Vol 25, Num 4, pp 2997-3001, issn 0250-7005, 5 p.Article

Correlation among the indices of high-resolution computed tomography, pulmonary function tests, pulmonary perfusion scans and exercise tolerance in cases of chronic pulmonary emphysemaFUJITA, Etsuo; NAGASAKA, Yukio; KOZUKA, Takenorii et al.Respiration (Basel). 2002, Vol 69, Num 1, pp 30-37, issn 0025-7931Article

Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent D-19575 (glufosfamide) in patients with solid tumorsSHIMIZU, Toshio; OKAMOTO, Isamu; TAMURA, Kenji et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 2, pp 243-250, issn 0344-5704, 8 p.Article

Regulatory T Cells Protect Mice Against Coxsackievirus-Induced Myocarditis Through the Transforming Growth Factor β-Coxsackie-Adenovirus Receptor PathwayYU SHI; FUKUOKA, Masahiro; GUOHUA LI et al.Circulation (New York, N.Y.). 2010, Vol 121, Num 24, pp 2624-2634, issn 0009-7322, 11 p.Article

Phase i study of tzt-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week coursesTAMURA, Kenji; NAKAGAWA, Kazuhiko; FUKUOKA, Masahiro et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 2, pp 285-293, issn 0344-5704, 9 p.Article

Pemetrexed- induced edema of the eyelidKURATA, Takayasu; TAMURA, Kenji; OKAMOTO, Isamu et al.Lung cancer. 2006, Vol 54, Num 2, pp 241-242, issn 0169-5002, 2 p.Article

Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer : Molecular analysis of the IDEAL/INTACT gefitinib trialsBELL, Daphne W; LYNCH, Thomas J; KREBS, Annetta D et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 8081-8092, issn 0732-183X, 12 p.Article

Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancerKANEDA, Hiroyasu; TAMURA, Kenji; KURATA, Takayasu et al.Lung cancer. 2004, Vol 46, Num 2, pp 247-254, issn 0169-5002, 8 p.Article

Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancerFUKUOKA, Masahiro; YANO, Seiji; EEK, Richard et al.Journal of clinical oncology. 2003, Vol 21, Num 12, pp 2237-2246, issn 0732-183X, 10 p.Article

A Phase I Study of Chemoradiotherapy With Use of Involved-Field Conformal Radiotherapy and Accelerated Hyperfractionation for Stage III Non-Small Cell Lung Cancer: WJTOG 3305TADA, Takuhito; CHIBA, Yasutaka; NAKANISHI, Yoichi et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 1, pp 327-331, issn 0360-3016, 5 p.Article

Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplificationYOSHIDA, Takeshi; OKAMOTO, Isamu; OKAMOTO, Wataru et al.Cancer science. 2010, Vol 101, Num 1, pp 167-172, issn 1347-9032, 6 p.Article

Gelsolin Regulates Cardiac Remodeling After Myocardial Infarction Through DNase I-Mediated ApoptosisGUO HUA LI; YU SHI; YOUAN LIU et al.Circulation research. 2009, Vol 104, Num 7, pp 896-904, issn 0009-7330, 9 p.Article

Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non―Small-Cell Lung Cancer: A Model for Assessing Population-Related PharmacogenomicsGANDARA, David R; KAWAGUCHI, Tomoya; GAUTSCHI, Oliver et al.Journal of clinical oncology. 2009, Vol 27, Num 21, pp 3540-3546, issn 0732-183X, 7 p.Article

Interstitial Lung Disease in Japanese Patients with Lung Cancer : A Cohort and Nested Case-Control StudyKUDOH, Shoji; KATO, Harubumi; HAIYI JIANG et al.American journal of respiratory and critical care medicine. 2008, Vol 177, Num 12, pp 1348-1357, issn 1073-449X, 10 p.Article

Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell LinesIWASA, Tsutomu; OKAMOTO, Isamu; SUZUKI, Minoru et al.Clinical cancer research (Print). 2008, Vol 14, Num 20, pp 6496-6504, issn 1078-0432, 9 p.Article

Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycinYONESAKA, Kimio; TAMURA, Kenji; KURATA, Takayasu et al.International journal of cancer. 2006, Vol 118, Num 4, pp 812-820, issn 0020-7136, 9 p.Article

Individually different weights of quality of life assessment in patients with advanced nonsmall-cell lung cancerMORITA, Satoshi; OHASHI, Yasuo; KOBAYASHI, Kunihiko et al.Journal of clinical epidemiology. 2003, Vol 56, Num 8, pp 744-751, issn 0895-4356, 8 p.Article

Point mutations in the topoisomerase I gene in patients with non-small cell lung cancer treated with irinotecanTSURUTANI, Junji; NITTA, Takashi; HIRASHIMA, Tomonori et al.Lung cancer. 2002, Vol 35, Num 3, pp 299-304, issn 0169-5002Article

Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS)YANG, James Chih-Hsin; WU, Yi-Long; CHAN, Valorie et al.Lung cancer. 2014, Vol 83, Num 2, pp 174-181, issn 0169-5002, 8 p.Article

A Phase 3 Study of Induction Treatment With Concurrent Chemoradiotherapy Versus Chemotherapy Before Surgery in Patients With Pathologically Confirmed N2 Stage IIIA Nonsmall Cell Lung Cancer (WJTOG9903)KATAKAMI, Nobuyuki; TADA, Hirohito; MITSUDOMI, Tetsuya et al.Cancer. 2012, Vol 118, Num 24, pp 6126-6135, issn 0008-543X, 10 p.Article